Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Online Network.
Press releases published on August 31, 2025
Dallas Foot and Ankle Specialist, Dr. Christopher Sakowski, Expands Specialized Surgeries for Foot and Ankle Conditions
DALLAS, TX, UNITED STATES, August 31, 2025 /EINPresswire.com/ -- Patients struggling with severe foot and ankle injuries now have expanded treatment options thanks to the advanced surgical expertise of Dr. Christopher Sakowski, a trusted Dallas foot and …
Anavar For Women And Men: CrazyBulk Launch Anavar Legal Steroid Alternative For Female Read Dosage, Side Effects, (Before and After Cycle results)
New York, Aug. 31, 2025 (GLOBE NEWSWIRE) -- August 31, 2025 | New York CrazyBulk proudly announces the release of Anavar (Anvarol), its legal and safe alternative to the anabolic steroid Anavar. Designed for cutting cycles, Anvarol helps users shred fat …
Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025
Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American College of Cardiology New Analysis Shows Annual Incidence Rate of Atrial Fibrillation …
Tourmaline Bio Presents Data from the Ongoing Phase 2 TRANQUILITY Trial at the 2025 European Society of Cardiology Congress
– Poster presentation highlights the consistency of reductions in high-sensitivity C-reactive protein with pacibekitug across clinically-meaningful subgroups – – Pacibekitug demonstrated concordant, statistically significant reductions in secondary …
Tenaya Therapeutics Presents Interim Data from MyClimb™ Natural History Study of MYBPC3-associated HCM Pediatric Patients at European Society of Cardiology Congress 2025
Largest Noninterventional Natural History Study of People Under 18 with MYBPC3-associated HCM with More than 200 Participants 93% of MyClimb Participants had the Nonobstructive Form of HCM for Which There Are No Approved Therapeutics Genotypic Status …
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025
DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 31, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted in vitro data assessing the effects of EPA on lipoprotein(a) [Lp(a)] oxidation and on cellular stress and inflammatory protein …
Mid-Year Healthcare Checkup: HSA for America Urges Americans to Review Coverage Before Fall Enrollment
Strategic Review Now Can Lead to Significant Savings During Open Enrollment Season FORT COLLINS, CO, UNITED STATES, August 30, 2025 /EINPresswire.com/ -- HSA for America is encouraging Americans to conduct a comprehensive mid-year healthcare review as …